Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis
Xiaodan Huang(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Guan‐Qun Zhou(Sun Yat-sen University), Huaqiang Zhou(Sun Yat-sen University), Xiaojun He(Harbin Medical University), Jun Ma(Shanghai Institute of Technology), Jia‐Wei Lv(Sun Yat-sen University), Chenwen Zhong(Sun Yat-sen University), Liang Peng(Chinese PLA General Hospital), Chen‐Fei Wu(Sun Yat-sen University), Zi‐Qi Zheng(Sun Yat-sen University)
Cited by 58
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
|PLoS ONE|2012|703
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
|Cancer Research|2019|423
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
|Journal of Clinical Oncology|2021|393